NMR and IR characterization of the aluminium complexes of norfloxacin and ciprofloxacin fluoroquinolones

Magnetic Resonance in Chemistry

Volumn 45, Issue 10, 2007, Pages 850-859

  Chattah, Ana K ^a   Linck, Yamila Garro ^a   Monti, Gustavo A ^a   Levstein, Patricia R ^a   Breda, Susana A ^a   Manzo, Rubén H ^a   Olivera, Maria E ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Aluminium complexes; Ciprofloxacin; Fluoroquinolone aluminium complexes; IR; NMR; Norfloxacin

Indexed keywords

ALUMINUM COMPOUNDS; ANTIBIOTICS; CARBON; CARBOXYLATION; COORDINATION REACTIONS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS (CHEMICAL);

ALUMINUM COMPLEXES; CIPROFLOXACIN; FLUOROQUINOLONE-ALUMINUM COMPLEX; FLUOROQUINOLONES; INFRARED CHARACTERIZATION; NORFLOXACIN; PROPERTY; SOLUTION STATE NUCLEAR MAGNETIC RESONANCE; SPECTRA'S;

MAGIC ANGLE SPINNING;

EID: 34748901752     PISSN: 07491581     EISSN: 1097458X     Source Type: Journal    
DOI: 10.1002/mrc.2058     Document Type: Article

References (31)

1. Fallati C. Master's Thesis, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 1994.
2. Olivera ME. PhD Thesis, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, 2000.
3. Yu X, Zipp GL, Ray Davison GW III. Pharm. Res. 1994; 11:522.
4. Lindenberg M, Kopp S, Dressman JB. Eur. J. Pharm. Biopharm. 2004; 58: 265.
5. Olivera ME, Bistoni A, Anun H, Salinas A, Manzo RH. Ear Nose Throat J. 2004; 83: 625 638.
6. Manzo RH, Mazzieri MR, Olivera ME, Preparación de complejos en estado sólido de clorhidratos de antimicrobianos fluoroquinoló nicos (AMFQs) con aluminio, Argentinian patent AR007762B1, 2005.
7. Allemandi DA, Alovero F, Manzo RH. Fármaco 1999; 54: 758.
8. Olivera ME, Mazzieri MR, Manzo RH. S.T.P. Pharm. Sci. 2000; 10: 251.
9. Olivera ME, Allemandi DA, Manzo RH. Acta Farm. Bonaerense 2000; 19:185.
10. Alovero FL, Olivera ME, Manzo RH. Int. J. Antimicrob. Agents 2003; 21: 446.
11. Bugay DE. Adv. Drug Deliv. Rev. 2001; 48: 43.
12. Byrn SR, Pfeiffer RR, Stowell JG. Solid State Chemistry of Drugs. SSCI: West-Lafayette Indiana, 1999.
13. Slichter CP. Principles of Magnetic Resonance. Springer: New York, 1992.
14. Tishmack PA, Bugay DE, Byrn SR, J. Pharm. Sci. 2003; 92:441.
15. Harris RK. Nuclear Magnetic Resonance Spectroscopy. Longman Scientific and Technical: London, 1994.
16. Yu L, Reutzel SM, Stephenson GA. Pharm. Sci. Technol. Today 1998; 1:118.
17. Turel I. Coord. Chem. Rev. 2002; 232:27.
18. Riley CM, Ross DL, Velde DV, Takusagawa F. J. Pharm. Biomed. Anal. 1993; 11: 49.
19. Sakai M, Hara A, Anjo S, Nakamura M. J. Pharm. Biomed. Anal. 1999; 18:1057.
20. Harris RK. Solid State Sci. 2004; 6:1025.
21. Granger P, Harris RK (eds). Multinuclear Magnetic Resonance in Liquids and Solids - Chemical Applications, NATO ASI Series C, vol. 322. Kluwer Academie Publishers: Dordrecht, The Netherlands, 1990; Chapt. 23;425.
22. Mazuel C. In Analytical Profiles of Drug Substances, vol. 20, Florey K (ed). Academic Press: San Diego, 1991; 557.
23. Bennet AE, Rienstra CM, Auger M, Lakshmi KV, Griffin RG, J. Chem. Phys. 1995; 103: 6951.
24. Gabriëlse W, Angad Gaur H, Feyen FC, Veeman WS. Macromolecules 1994; 27: 5811.
25. Neugebauer U, Szeghalmi A, Schdmitt M, Kieffer W, Popp J, Holzgrabe U. Spectrochim. Acta, Part A 2005; 61:1505.
26. Olivera ME, Rigo M, Chattah AK, Levstein PR, Baschini M, Manzo R. Eur. J. Pharm. Sci. 2003; 18: 337.
27. Okabayashi Y, Hayashi F, Terui Y, Kitagawa T. Chem. Pharm. Bull. 1992; 40: 692.
28. Mendoza-Díaz G, Ireta-Moreno J. J. Inorg. Biochem. 1994; 54:235.
29. Grant DM, Harris RK (eds). Encyclopedia of Nuclear Magnetic Resonance - Advances in NMR, vol. 9. John Wiley & Sons: Chichester, UK, 2002; 226, 262.
30. Beherens NB, Mendoza Díaz G, Goodgame DML. Inorg. Chim. Acta 1986; 125: 21.
31. Turel I, Bukovec P, Quiros M. Int. J. Pharm. 1997; 152: 59.